Cardiac Enzyme Tests: Their Role in Detecting Heart Muscle Damage

Introduction to Cardiac Enzymes and Biomarkers

Cardiovascular diseases, particularly acute myocardial infarction (heart attack), represent a major health challenge globally and within the Kingdom of Saudi Arabia. In emergency situations characterized by sudden chest pain, time is of the essence to save lives and minimize myocardial tissue damage. This is where the clinical utility of cardiac biomarkers, commonly referred to as cardiac enzyme tests, becomes vital.

When heart muscle cells are damaged or die due to a lack of blood flow and oxygen (ischemia), they release specific proteins and enzymes into the bloodstream. Measuring the levels of these substances helps emergency physicians accurately and rapidly determine if a patient is experiencing a heart attack, enabling immediate, life-saving interventions.

Key Types of Cardiac Biomarkers

Although commonly referred to as "cardiac enzymes," modern clinical practice primarily measures highly specific proteins rather than enzymes. These biomarkers include:

1. Cardiac Troponin (Troponin I & T)

The troponin test is the gold standard and most specific biomarker for detecting cardiac muscle injury. Troponins are regulatory proteins involved in muscle contraction. Cardiac-specific isoforms (cTnI and cTnT) are normally present in negligible amounts in the blood. However, even minor myocardial damage causes these levels to rise significantly within hours, remaining elevated for days.

Modern emergency departments in Saudi Arabia utilize "High-Sensitivity Troponin" (hs-cTn) assays. These advanced tests detect minute levels of myocardial injury much earlier than conventional assays, significantly accelerating clinical decision-making.

2. Creatine Kinase-MB (CK-MB)

Creatine kinase is an enzyme found in various tissues, but the CK-MB isoenzyme is highly concentrated in cardiac muscle. Historically, CK-MB was the primary marker for diagnosing heart attacks before the advent of troponin assays. While no longer the first-line choice, it remains useful in specific scenarios, such as detecting a second heart attack (re-infarction) shortly after the first, as its levels return to baseline much faster than troponin.

3. Myoglobin

Myoglobin is a small, oxygen-binding protein found in both cardiac and skeletal muscle cells. It is released very rapidly following muscle injury (within 1 to 2 hours). However, it lacks specificity for cardiac tissue, as skeletal muscle trauma can also elevate its levels. Consequently, it is never used in isolation to diagnose a myocardial infarction.

Indications for Cardiac Enzyme Testing

Cardiac biomarker testing is ordered on an emergency basis when acute coronary syndrome (ACS) or myocardial infarction is suspected. Symptoms prompting immediate evaluation include:

• Severe chest pain, pressure, or a squeezing sensation in the center of the chest.
• Pain radiating to the shoulder, left arm, back, neck, or jaw.
• Unexplained shortness of breath (dyspnea).
• Sudden, profuse cold sweating (diaphoresis).
• Dizziness, lightheadedness, nausea, or profound weakness.
• Rapid or irregular heart palpitations.

Procedure and Preparation

The test is performed via a standard blood draw from a vein in the arm. Because this is an emergency investigation, no special preparation or fasting is required. The blood sample is immediately sent to the laboratory for a comprehensive blood chemistry panel and cardiac markers, with results typically available within minutes to facilitate rapid triage.

Comparison of Major Cardiac Biomarkers

The following table outlines the temporal and clinical differences between the primary biomarkers used to evaluate myocardial injury:

Interpreting Results and Serial Testing

A single normal (negative) cardiac enzyme result upon arrival at the emergency department does not entirely rule out a heart attack, especially if symptoms started very recently. These biomarkers require time to accumulate in the bloodstream at detectable levels.

Therefore, clinical protocols mandate serial testing, where blood samples are drawn at specific intervals (e.g., at presentation, then at 3 hours, and 6 hours). Tracking the kinetic curve of rising or falling levels helps confirm the diagnosis and monitor clinical stability.

Non-Cardiac Causes of Elevated Biomarkers

It is clinically important to recognize that elevated troponin levels do not always indicate a classic heart attack caused by coronary artery occlusion. Other medical conditions can cause myocardial strain or minor injury, including:

• Chronic or acute kidney disease (due to reduced clearance of troponin).
• Myocarditis (inflammation of the heart muscle) or pericarditis.
• Acute pulmonary embolism (blood clot in the lungs).
• Severe sepsis or septic shock.
• Sustained severe tachyarrhythmias (rapid heart rate).
• Extreme, strenuous physical exertion (such as running a marathon).

Clinical Management and Next Steps

Based on cardiac enzyme levels and electrocardiogram (ECG) findings, the medical team determines the appropriate therapeutic pathway:

If Results are Positive (Elevated):

A diagnosis of myocardial injury or infarction is established. The patient is immediately transferred to a coronary care unit (CCU) or a cardiac catheterization laboratory for urgent angiography and potential percutaneous coronary intervention (PCI) to restore blood flow, alongside antiplatelet and anticoagulant therapy.

If Results are Negative (Normal) but Symptoms Persist:

The patient may remain under observation for further serial testing, echocardiography, or a stress test to ensure adequate myocardial perfusion before safe discharge.

Conclusion and Safety Guidance

At LahaLak, we emphasize that chest pain must always be treated as a medical emergency until proven otherwise. Never wait to see if the pain subsides on its own. Do not drive yourself to a clinic; instead, immediately seek emergency medical care by calling the Saudi Red Crescent at (997) or the Ministry of Health helpline at (937).